de Boer JP - Search Results

1

Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats.

de Smet BJ, de Boer JP, Agterberg J, Rigter G, Bleeker WK, Hack CE. de Smet BJ, et al. Among authors: de boer jp. Blood. 1993 Jan 1;81(1):56-61. Blood. 1993. PMID: 8417802 Free article.

2

Interplay of complement and cytokines in the pathogenesis of septic shock.

de Boer JP, Wolbink GJ, Thijs LG, Baars JW, Wagstaff J, Hack CE. de Boer JP, et al. Immunopharmacology. 1992 Sep-Oct;24(2):135-48. doi: 10.1016/0162-3109(92)90019-9. Immunopharmacology. 1992. PMID: 1473964 Review.

3

Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.

Levi M, Roem D, Kamp AM, de Boer JP, Hack CE, ten Cate JW. Levi M, et al. Among authors: de boer jp. Thromb Haemost. 1993 Feb 1;69(2):141-6. Thromb Haemost. 1993. PMID: 7681223

4

Controlled insect-sting challenge in 55 patients: correlation between activation of plasminogen and the development of anaphylactic shock.

van der Linden PW, Hack CE, Struyvenberg A, Roem D, Brouwer MC, de Boer JP, van der Zwan JK. van der Linden PW, et al. Among authors: de boer jp. Blood. 1993 Sep 15;82(6):1740-8. Blood. 1993. PMID: 7691234 Free article.

5

Activation of the complement system in baboons challenged with live Escherichia coli: correlation with mortality and evidence for a biphasic activation pattern.

de Boer JP, Creasey AA, Chang A, Roem D, Eerenberg AJ, Hack CE, Taylor FB Jr. de Boer JP, et al. Infect Immun. 1993 Oct;61(10):4293-301. doi: 10.1128/iai.61.10.4293-4301.1993. Infect Immun. 1993. PMID: 8406818 Free PMC article.

6

Analysis of intraarticular fibrinolytic pathways in patients with inflammatory and noninflammatory joint diseases.

Kummer JA, Abbink JJ, de Boer JP, Roem D, Nieuwenhuys EJ, Kamp AM, Swaak TJ, Hack CE. Kummer JA, et al. Among authors: de boer jp. Arthritis Rheum. 1992 Aug;35(8):884-93. doi: 10.1002/art.1780350806. Arthritis Rheum. 1992. PMID: 1379429

7

Fibrinolytic response to tumor necrosis factor in healthy subjects.

van der Poll T, Levi M, Büller HR, van Deventer SJ, de Boer JP, Hack CE, ten Cate JW. van der Poll T, et al. Among authors: de boer jp. J Exp Med. 1991 Sep 1;174(3):729-32. doi: 10.1084/jem.174.3.729. J Exp Med. 1991. PMID: 1714936 Free PMC article.

8

Alpha-2-macroglobulin functions as an inhibitor of fibrinolytic, clotting, and neutrophilic proteinases in sepsis: studies using a baboon model.

de Boer JP, Creasey AA, Chang A, Abbink JJ, Roem D, Eerenberg AJ, Hack CE, Taylor FB Jr. de Boer JP, et al. Infect Immun. 1993 Dec;61(12):5035-43. doi: 10.1128/iai.61.12.5035-5043.1993. Infect Immun. 1993. PMID: 7693593 Free PMC article.

9

Coagulation disorders in septic shock.

Thijs LG, de Boer JP, de Groot MC, Hack CE. Thijs LG, et al. Among authors: de groot mc, de boer jp. Intensive Care Med. 1993;19 Suppl 1:S8-15. doi: 10.1007/BF01738944. Intensive Care Med. 1993. PMID: 8227738 Review.

10

Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli.

de Boer JP, Creasy AA, Chang A, Roem D, Brouwer MC, Eerenberg AJ, Hack CE, Taylor FB Jr. de Boer JP, et al. Circ Shock. 1993 Jan;39(1):59-67. Circ Shock. 1993. PMID: 7683256

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

118 results

Search Page

Filters